首页> 外文期刊>Neurogastroenterology and motility >Association of low numbers of CD206-positive cells with loss of ICC in the gastric body of patients with diabetic gastroparesis
【24h】

Association of low numbers of CD206-positive cells with loss of ICC in the gastric body of patients with diabetic gastroparesis

机译:糖尿病胃轻瘫患者胃癌中CD206阳性细胞数量少与ICC丢失的关系

获取原文
获取原文并翻译 | 示例
           

摘要

Background There is increasing evidence for specific cellular changes in the stomach of patients with diabetic (DG) and idiopathic (IG) gastroparesis. The most significant findings are loss of interstitial cells of Cajal (ICC), neuronal abnormalities, and an immune cellular infiltrate. Studies done in diabetic mice have shown a cytoprotective effect of CD206+ M2 macrophages. To quantify overall immune cellular infiltrate, identify macrophage populations, and quantify CD206+ and iNOS+ cells. To investigate associations between cellular phenotypes and ICC. Methods Full thickness gastric body biopsies were obtained from non-diabetic controls (C), diabetic controls (DC), DG, and IG patients. Sections were labeled for CD45, CD206, Kit, iNOS, and putative human macrophage markers (HAM56, CD68, and EMR1). Immunoreactive cells were quantified from the circular muscle layer. Key Results Significantly fewer ICC were detected in DG and IG tissues, but there were no differences in the numbers of cells immunoreactive for other markers between patient groups. There was a significant correlation between the number of CD206+ cells and ICC in DG and DC patients, but not in C and IG and a significant correlation between iNOS+ cells and ICC in the DC group, but not the other groups. CD68 and HAM56 reliably labeled the same cell populations, but EMR1 labeled other cell types. Conclusions & Inferences Depletion of ICC and correlation with changes in CD206+ cell numbers in DC and DG patients suggests that in humans, like mice, CD206+ macrophages may play a cytoprotective role in diabetes. These findings may lead to novel therapeutic options, targeting alternatively activated macrophages.
机译:背景技术越来越多的证据表明患有糖尿病(DG)和特发性(IG)胃轻瘫的患者的胃中会发生特定的细胞变化。最重要的发现是Cajal间质细胞(ICC)丢失,神经元异常和免疫细胞浸润。在糖尿病小鼠中进行的研究表明,CD206 + M2巨噬细胞具有细胞保护作用。为了量化整体免疫细胞浸润,鉴定巨噬细胞种群,并量化CD206 +和iNOS +细胞。调查细胞表型和ICC之间的关联。方法从非糖尿病对照(C),糖尿病对照(DC),DG和IG患者获得胃全层活检。将切片标记为CD45,CD206,试剂盒,iNOS和假定的人类巨噬细胞标记(HAM56,CD68和EMR1)。从环形肌层定量免疫反应性细胞。关键结果在DG和IG组织中检测到的ICC显着减少,但患者组之间对其他标志物具有免疫反应性的细胞数量没有差异。 DG和DC患者中CD206 +细胞数量与ICC之间存在显着相关性,而C和IG患者中CD206 +细胞数量与ICC之间无显着相关性,DC组而非其他组中iNOS +细胞与ICC之间存在显着相关性。 CD68和HAM56可靠地标记了相同的细胞群,而EMR1标记了其他细胞类型。结论与推断DC和DG患者的ICC耗竭及其与CD206 +细胞数量变化的相关性表明,在人类中,如小鼠一样,CD206 +巨噬细胞可能在糖尿病中发挥细胞保护作用。这些发现可能导致针对交替激活的巨噬细胞的新型治疗选择。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号